Abstract:A virologic marker, the number of HIV RNA copies or viral load, is currently used to evaluate antiretroviral (ARV) therapies in AIDS clinical trials. This marker can be used to assess the ARV potency of therapies, but is easily affected by drug exposures, drug resistance and other factors during the long-term treatment evaluation process. HIV dynamic studies have significantly contributed to the understanding of HIV pathogenesis and ARV treatment strategies. However, the models of these studies are used to quantify short-term HIV dynamics ($<$ 1 month), and are not applicable to describe long-term virological response to ARV treatment due to the difficulty of establishing a relationship of antiviral response with multiple treatment factors such as drug exposure and drug susceptibility during long-term treatment. Long-term therapy with ARV agents in HIV-infected patients often results in failure to suppress the viral load. Pharmacokinetics (PK), drug resistance and imperfect adherence to prescribed antiviral drugs are important factors explaining the resurgence of virus. To better understand the factors responsible for the virological failure, this paper develops the mechanism-based nonlinear differential equation models for characterizing long-term viral dynamics with ARV therapy. The models directly incorporate drug concentration, adherence and drug susceptibility into a function of treatment efficacy and, hence, fully integrate virologic, PK, drug adherence and resistance from an AIDS clinical trial into the analysis. A Bayesian nonlinear mixed-effects modeling approach in conjunction with the rescaled version of dynamic differential equations is investigated to estimate dynamic parameters and make inference. In addition, the correlations of baseline factors with estimated dynamic parameters are explored and some biologically meaningful correlation results are presented. Further, the estimated dynamic parameters in patients with virologic success were compared to those in patients with virologic failure and significantly important findings were summarized. These results suggest that viral dynamic parameters may play an important role in understanding HIV pathogenesis, designing new treatment strategies for long-term care of AIDS patients.

Piecewise virus-immune dynamic model with HIV-1 RNA-guided therapy

A Piecewise Model of Virus-Immune System with Effector Cell-Guided Therapy

Piecewise HIV Virus Dynamic Model with CD4(+) T Cell Count-Guided Therapy: I.

Piecewise immunosuppressive infection model with viral logistic growth and effector cell-guided therapy

A Piecewise Model of Virus-Immune System with Two Thresholds

Global Dynamics of a Virus-Immune System with Virus-Guided Therapy and Saturation Growth of Virus

Mathematical analysis of an HIV model with latent reservoir, delayed CTL immune response and immune impairment

Modeling virus-stimulated proliferation of CD4+ T-cell, cell-to-cell transmission and viral loss in HIV infection dynamics

Dynamic analysis of an HIV model with CTL immune response and logarithmic Ornstein–Uhlenbeck process

Dynamic analysis and optimal control of a fractional order HIV/HTLV co-infection model with HIV-specific antibody immune response

An HIV stochastic model with cell-to-cell infection, B-cell immune response and distributed delay

Sliding mode dynamics and optimal control for HIV model

Dynamic model of HIV infection with immune system response of T-lymphocytes, B-cells and dendritic cells: a review

Bistability of an HIV Model with Immune Impairment

Dynamics and optimal therapy of a stochastic HTLV‐1 model incorporating Ornstein–Uhlenbeck process

Global dynamics of a non-smooth SIV system with uncertain effective vaccine protection rate

Continuous and discrete dynamics of a deterministic model of HIV infection

A Quantitative Analysis of Dynamic Mechanisms Regulating HIV Latency and Activation

A mathematical model for HIV dynamics with multiple infections: implications for immune escape

Stability analysis for a HIV model with cell-to-cell transmission, two immune responses and induced apoptosis

Modeling long-term longitudinal HIV dynamics with application to an AIDS clinical study